Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer

Clinical trial NCT03750669 · COMPLETED

Trial details

NCT number: NCT03750669
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma Resectable Neoadjuvant Chemotherapy

Start date: 2018-10-20
Primary completion: 2024-11-01
Enrollment: 324

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.